levothyroxine sodium accord
accord healthcare b.v. - levotiroksino natrio druska - tabletės - 75 µg - levothyroxine sodium
levothyroxine sodium accord
accord healthcare b.v. - levotiroksino natrio druska - tabletės - 88 µg - levothyroxine sodium
levothyroxine sodium accord
accord healthcare b.v. - levotiroksino natrio druska - tabletės - 112 µg - levothyroxine sodium
levothyroxine sodium accord
accord healthcare b.v. - levotiroksino natrio druska - tabletės - 125 µg - levothyroxine sodium
levothyroxine sodium accord
accord healthcare b.v. - levotiroksino natrio druska - tabletės - 137 µg - levothyroxine sodium
levothyroxine sodium accord
accord healthcare b.v. - levotiroksino natrio druska - tabletės - 150 µg - levothyroxine sodium
levothyroxine sodium accord
accord healthcare b.v. - levotiroksino natrio druska - tabletės - 175 µg - levothyroxine sodium
levothyroxine sodium accord
accord healthcare b.v. - levotiroksino natrio druska - tabletės - 200 µg - levothyroxine sodium
zenalpha
vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psichopatologija, hipnotizai ir raminamieji preparatai - Šunys - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.
xenpozyme
sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - kiti virškinimo trakto ir metabolizmo produktus, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.